Breast Cancer Clinical Trial
Screening CEDM in Intermediate and High-Risk Patient Populations
This research study is being done to determine if Contrast Enhanced Digital Mammography (CEDM) can improve breast cancer detection and can be used as an additional screening method to the standard mammographic screening.
Women aged 35 and had a negative routine mammogram within 6 months.
Qualifies as intermediate or high-risk (>15% lifetime risk of breast cancer as defined by IBIS version 8).
Known breast cancer
Previously had negative MBI or MRI within 12 months of study
Pregnant or lactating
Contraindication to intravenous iodinated contrast
Unable to understand or sign informed consent
Self-reported signs or symptoms of breast cancer
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Scottsdale Arizona, 85259, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.